BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 9310957)

  • 1. Cyclin D1 protein in multiple myeloma and plasmacytoma: an immunohistochemical study using fixed, paraffin-embedded tissue sections.
    Vasef MA; Medeiros LJ; Yospur LS; Sun NC; McCourty A; Brynes RK
    Mod Pathol; 1997 Sep; 10(9):927-32. PubMed ID: 9310957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclin D1 overexpression in multiple myeloma. A morphologic, immunohistochemical, and in situ hybridization study of 71 paraffin-embedded bone marrow biopsy specimens.
    Athanasiou E; Kaloutsi V; Kotoula V; Hytiroglou P; Kostopoulos I; Zervas C; Kalogiannidis P; Fassas A; Christakis JI; Papadimitriou CS
    Am J Clin Pathol; 2001 Oct; 116(4):535-42. PubMed ID: 11601138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of cyclin D1 mRNA overexpression in B-cell neoplasias by real-time reverse transcription-PCR of microdissected paraffin sections.
    Specht K; Kremer M; Müller U; Dirnhofer S; Rosemann M; Höfler H; Quintanilla-Martinez L; Fend F
    Clin Cancer Res; 2002 Sep; 8(9):2902-11. PubMed ID: 12231535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In situ hybridization and reverse transcription-polymerase chain reaction for cyclin D1 mRNA in the diagnosis of mantle cell lymphoma in paraffin-embedded tissues.
    Athanasiou E; Kotoula V; Hytiroglou P; Kouidou S; Kaloutsi V; Papadimitriou CS
    Mod Pathol; 2001 Feb; 14(2):62-71. PubMed ID: 11235907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical analysis identifies two cyclin D1+ subsets of plasma cell myeloma, each associated with favorable survival.
    Cook JR; Hsi ED; Worley S; Tubbs RR; Hussein M
    Am J Clin Pathol; 2006 Apr; 125(4):615-24. PubMed ID: 16627271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical significance of cyclin D1, fibroblast growth factor receptor 3, and p53 immunohistochemistry in plasma cell myeloma treated with a thalidomide-based regimen.
    Kelley TW; Baz R; Hussein M; Karafa M; Cook JR
    Hum Pathol; 2009 Mar; 40(3):405-12. PubMed ID: 19070887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The (11;14)(q13;q32) translocation in multiple myeloma. A morphologic and immunohistochemical study.
    Hoyer JD; Hanson CA; Fonseca R; Greipp PR; Dewald GW; Kurtin PJ
    Am J Clin Pathol; 2000 Jun; 113(6):831-7. PubMed ID: 10874884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved diagnostic segregation of mantle cell lymphoma by determination of cyclin D1/D3 expression ratio in formalin-fixed tissue.
    Mangseth K; Helgeland L; Klos J; Molven A; Vintermyr OK
    Diagn Mol Pathol; 2009 Sep; 18(3):150-5. PubMed ID: 19704260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical detection of cyclin D1 using optimized conditions is highly specific for mantle cell lymphoma and hairy cell leukemia.
    Miranda RN; Briggs RC; Kinney MC; Veno PA; Hammer RD; Cousar JB
    Mod Pathol; 2000 Dec; 13(12):1308-14. PubMed ID: 11144927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional regulation of D-type cyclins by insulin-like growth factor-I and serum in multiple myeloma cells.
    Glassford J; Rabin N; Lam EW; Yong KL
    Br J Haematol; 2007 Oct; 139(2):243-54. PubMed ID: 17897300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravascular large B-cell lymphoma: the CD5 antigen is expressed by a subset of cases.
    Khalidi HS; Brynes RK; Browne P; Koo CH; Battifora H; Medeiros LJ
    Mod Pathol; 1998 Oct; 11(10):983-8. PubMed ID: 9796727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutually exclusive cyclin-dependent kinase 4/cyclin D1 and cyclin-dependent kinase 6/cyclin D2 pairing inactivates retinoblastoma protein and promotes cell cycle dysregulation in multiple myeloma.
    Ely S; Di Liberto M; Niesvizky R; Baughn LB; Cho HJ; Hatada EN; Knowles DM; Lane J; Chen-Kiang S
    Cancer Res; 2005 Dec; 65(24):11345-53. PubMed ID: 16357141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequency and distribution of trisomy 11 in multiple myeloma patients: relation with overexpression of CCND1 and t(11;14).
    Guglielmelli T; Giugliano E; Cappia S; Papotti M; Saglio G
    Cancer Genet Cytogenet; 2007 Feb; 173(1):51-6. PubMed ID: 17284370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Expression of cyclin D1 and vascular endothelial growth factor(VEGF) in non-small cell lung carcinoma and their association with the prognosis].
    Liang RY; Liao ZS; Jiang SP; Zhang W; Li JG; Zheng DH
    Ai Zheng; 2003 Jan; 22(1):86-90. PubMed ID: 12561444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered expression of cell cycle regulatory proteins in benign and malignant bone and soft tissue neoplasms.
    Bui MM; Bagui TK; Boulware DC; Letson DG; Nasir A; Kaiser HE; Pledger WJ; Coppola D
    In Vivo; 2007; 21(5):729-37. PubMed ID: 18019405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alteration of cyclin D1 in Chinese patients with breast carcinoma and its correlation with Ki-67, pRb, and p53.
    Guo LL; Gao P; Wu YG; Jian WC; Hao CY; Li H; Lin XY
    Arch Med Res; 2007 Nov; 38(8):846-52. PubMed ID: 17923265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclin D1 overexpression is not a specific grouping marker, but may collaborate with CDC37 in myeloma cells.
    Katayama Y; Sakai A; Okikawa Y; Oue N; Asaoku H; Sasaki A; Imanaka F; Tsujimoto T; Takimoto Y; Masuda R; Nakaju N; Otsuki T; Yasui W; Kimura A
    Int J Oncol; 2004 Sep; 25(3):579-95. PubMed ID: 15289859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclin D1 expression in transitional cell carcinoma of the bladder: correlation with p53, waf1, pRb and Ki67.
    Tut VM; Braithwaite KL; Angus B; Neal DE; Lunec J; Mellon JK
    Br J Cancer; 2001 Jan; 84(2):270-5. PubMed ID: 11161387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclin D1 positive multiple myeloma: predominance of the short, 3'UTR-deficient transcript is associated with high cyclin D1 mRNA levels in cases with t(11;14) translocation, but does not correlate with proliferation rate or genomic deletions.
    Slotta-Huspenina J; Koch I; Richter M; Bink K; Kremer M; Specht K; Krugmann J; Quintanilla-Martinez L; Fend F
    Leuk Res; 2008 Jan; 32(1):79-88. PubMed ID: 17629555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of cyclin D1 in parathyroid carcinomas, adenomas, and hyperplasias: a paraffin immunohistochemical study.
    Vasef MA; Brynes RK; Sturm M; Bromley C; Robinson RA
    Mod Pathol; 1999 Apr; 12(4):412-6. PubMed ID: 10229506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.